awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33421108-5A270244-20EC-4618-8FA9-A721966EF9F7
Q33421108-5A270244-20EC-4618-8FA9-A721966EF9F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421108-5A270244-20EC-4618-8FA9-A721966EF9F7
Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis.
P2860
Q33421108-5A270244-20EC-4618-8FA9-A721966EF9F7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33421108-5A270244-20EC-4618-8FA9-A721966EF9F7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
ad015041e685d8980d50e382e8c119e860faa631
P2860
Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms